Cargando…
Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603623/ http://dx.doi.org/10.1186/2052-3211-8-S1-O10 |
_version_ | 1782394925879394304 |
---|---|
author | Spillane, Susan Usher, Cara Bennett, Kathleen Adams, Roisin Barry, Michael |
author_facet | Spillane, Susan Usher, Cara Bennett, Kathleen Adams, Roisin Barry, Michael |
author_sort | Spillane, Susan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4603623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46036232015-10-14 Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors Spillane, Susan Usher, Cara Bennett, Kathleen Adams, Roisin Barry, Michael J Pharm Policy Pract Oral Presentation BioMed Central 2015-10-05 /pmc/articles/PMC4603623/ http://dx.doi.org/10.1186/2052-3211-8-S1-O10 Text en Copyright © 2015 Spillane et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Spillane, Susan Usher, Cara Bennett, Kathleen Adams, Roisin Barry, Michael Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
title | Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
title_full | Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
title_fullStr | Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
title_full_unstemmed | Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
title_short | Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
title_sort | introduction of generic substitution and reference pricing in ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603623/ http://dx.doi.org/10.1186/2052-3211-8-S1-O10 |
work_keys_str_mv | AT spillanesusan introductionofgenericsubstitutionandreferencepricinginirelandearlyeffectsonstatepharmaceuticalexpenditureandgenericpenetrationandassociatedsuccessfactors AT ushercara introductionofgenericsubstitutionandreferencepricinginirelandearlyeffectsonstatepharmaceuticalexpenditureandgenericpenetrationandassociatedsuccessfactors AT bennettkathleen introductionofgenericsubstitutionandreferencepricinginirelandearlyeffectsonstatepharmaceuticalexpenditureandgenericpenetrationandassociatedsuccessfactors AT adamsroisin introductionofgenericsubstitutionandreferencepricinginirelandearlyeffectsonstatepharmaceuticalexpenditureandgenericpenetrationandassociatedsuccessfactors AT barrymichael introductionofgenericsubstitutionandreferencepricinginirelandearlyeffectsonstatepharmaceuticalexpenditureandgenericpenetrationandassociatedsuccessfactors |